← All countries · Americas
90%
MCV1
2018 · Administrative (country-reported)
89%
DTP3
2018 · Administrative (country-reported)
84%
HepB3
2018 · Administrative (country-reported)
0
Measles cases
2018 reported
0
Pertussis (whooping cough) cases
2018 reported
Two kinds of number live on this page. Coverage is the share of the target cohort vaccinated, as estimated by WHO and UNICEF each July from the country's reports, surveys and other evidence, shown beside what the country itself reported. Reported cases are what the national surveillance system sent to WHO; they are a floor, not a count of infections. Every row carries a grade; hover or focus it for the reason, or read how grades are assigned.
Vaccination coverage
| Vaccine | Latest estimate | Country-reported | Trend since 2000 | Data quality |
|---|---|---|---|---|
| BCGTuberculosis vaccine at birth | —% · Administrative (country-reported) | — | too few points | no data |
| DTP1First dose of diphtheria-tetanus-pertussis | 91%2018 · Administrative (country-reported) | 91% | D · poor | |
| DTP3Third dose of diphtheria-tetanus-pertussis (the WHO benchmark of a working programme) | 89%2018 · Administrative (country-reported) | 89% | D · poor | |
| IPV1First dose of inactivated polio vaccine | 91%2018 · Administrative (country-reported) | 91% | D · poor | |
| MCV1First dose of measles-containing vaccine | 90%2018 · Administrative (country-reported) | 90% | D · poor | |
| MCV2Second dose of measles-containing vaccine | —% · Administrative (country-reported) | — | too few points | no data |
| RCV1First dose of rubella-containing vaccine | 90%2018 · Administrative (country-reported) | 90% | D · poor | |
| HepB3Third dose of hepatitis B vaccine | 84%2018 · Administrative (country-reported) | 84% | D · poor | |
| HepB birthHepatitis B birth dose within 24 hours | —% · Administrative (country-reported) | — | too few points | no data |
| Hib3Third dose of Haemophilus influenzae type b vaccine | 89%2018 · Administrative (country-reported) | 89% | D · poor | |
| PCV1Pneumococcal conjugate vaccine, first dose | 88%2018 · Administrative (country-reported) | 88% | D · poor | |
| PCV completePneumococcal conjugate vaccine, final dose of the schedule | 91%2018 · Administrative (country-reported) | 91% | D · poor | |
| RotaCRotavirus vaccine, complete series | —% · Administrative (country-reported) | — | too few points | no data |
| Yellow feverYellow fever vaccine (countries at risk) | —% · Administrative (country-reported) | — | too few points | no data |
| MenAMeningococcal A conjugate (meningitis belt) | —% · Administrative (country-reported) | — | too few points | no data |
| JEJapanese encephalitis vaccine (countries at risk) | —% · Administrative (country-reported) | — | too few points | no data |
| PABProtection at birth against neonatal tetanus (maternal tetanus doses) | —% · Administrative (country-reported) | — | too few points | no data |
Reported vaccine-preventable disease
| Disease | Reported cases | Incidence rate | Trend since 2000 | Data quality |
|---|---|---|---|---|
| Measles all countries · vaccine evidence | 02018 | 0per 1,000,000 total population | D · poor | |
| Rubella all countries · vaccine evidence | 02018 | 0per 1,000,000 total population | D · poor | |
| Congenital rubella syndrome all countries · vaccine evidence | 02018 | 0per 10,000 live births | D · poor | |
| Mumps all countries · vaccine evidence | 12018 | 25.2per 1,000,000 total population | D · poor | |
| Pertussis (whooping cough) all countries · vaccine evidence | 02018 | 0per 1,000,000 total population | D · poor | |
| Diphtheria all countries · vaccine evidence | 02018 | 0per 1,000,000 total population | D · poor | |
| Tetanus (total) all countries · vaccine evidence | 02018 | 0per 1,000,000 total population | D · poor | |
| Neonatal tetanus all countries · vaccine evidence | 02018 | 0per 1,000 live births | D · poor | |
| Polio (paralytic) all countries · vaccine evidence | 02018 | 0per 1,000,000 <15 population | too few points | D · poor |
| Yellow fever all countries · vaccine evidence | 02018 | 0per 1,000,000 total population | D · poor | |
| Typhoid all countries · vaccine evidence | 02018 | 0per 1,000,000 total population | too few points | D · poor |
National schedule (latest WHO listing)
Show the schedule (20 rows)
| Vaccine | Dose | Age | Target group | Comment |
|---|---|---|---|---|
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 1 | M2 | General/routine | |
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 2 | M3 | General/routine | |
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 3 | M4 | General/routine | |
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 4 | M12 | General/routine | |
| DTIPVDT-IPV (Diphtheria and tetanus toxoid and IPV) vaccine | 5 | Y4 | General/routine | |
| DTIPVDT-IPV (Diphtheria and tetanus toxoid and IPV) vaccine | 6 | Y9 | General/routine | |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 1 | 1st contact | Risk group(s) | for risk group adults and children over 55kg |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 2 | +M1 | Risk group(s) | for risk group adults and children over 55kg |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 3 | +M7 | Risk group(s) | for risk group adults and children over 55kg |
| HEPB_PEDIATRICPediatric Hepatitis B (HepB) vaccine | 1 | M2 | General/routine | |
| HEPB_PEDIATRICPediatric Hepatitis B (HepB) vaccine | 2 | M3 | General/routine | |
| HEPB_PEDIATRICPediatric Hepatitis B (HepB) vaccine | 3 | M6 | General/routine | |
| HPV9HPV-9 (Human papillomavirus 9-valent) vaccine | 1 | +M6 | HPV for females only | females in primary school; switched to nonavalent in 2018 |
| HPV9HPV-9 (Human papillomavirus 9-valent) vaccine | 2 | Y9-Y11 | HPV for females only | females in primary school; switched to nonavalent in 2018 |
| MMRMMR (Measles, mumps and rubella) vaccine | 1 | Y1 | General/routine | |
| MMRMMR (Measles, mumps and rubella) vaccine | 2 | Y4 | General/routine | |
| PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine | 1 | M4 | General/routine | |
| PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine | 2 | M6 | General/routine | |
| PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine | 3 | M15 | General/routine | |
| YFYF (Yellow fever) vaccine | 1 | 1st contact | Risk group(s) | travellers to endemic countries |
Compare schedules across 31 countries on the schedule hub.
Data and sources
- Download this country's data (JSON): every year, every antigen and disease, with the grade reasons.
- Coverage: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and country-reported administrative/official coverage, from the WHO Immunization Data Portal export downloaded 21 October 2026.
- Reported cases and incidence: WHO/UNICEF Joint Reporting Form, same export. Incidence denominators are stated per row.
- Schedule: WHO vaccine-schedule export, latest listing year.